Not finding it? Sign in to also search OpenAlex live.
-
Umbilical Cord Blood as an Alternative to Neonatal Blood for Complete Blood Count: A Comparison Study2024 The Journal of Pediatrics article Medicine Clinical Laboratory Practices and Quality Control Open access
Lisanne E. Heeger, Myrthe I.J. Koster, Camila Caram‐Deelder, Vincent Bekker, Johanna G. van der Bom, Enrico Lopriore
6citations -
Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial2026 Blood Cancer Journal article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Steffen Koschmieder, Susanne Isfort, Lino Lars Teichmann, Philippe Schafhausen, Florian Heinrich Heidel, Carl C. Crodel, +22 more
0citations -
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Florian Heinrich Heidel, Andreas Hochhaus, Heiko Becker, Philipp Jakob Jost, +19 more
3citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion
Arjan A. van de Loosdrecht, Jacqueline J Cloos, Eva‐Maria Wagner‐Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina H. M. J. van Elssen, +6 more
1citations -
Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial
Christoph Röllig, Björn Steffen, Nael Alakel, Regina Herbst, Richard Noppeney, Maher Hanoun, +32 more
5citations -
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia2021 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Christoph Schmid, Myriam Labopin, Nicolaas PM Schaap, Hendrik Veelken, Arne Brecht, Michael Beda Stadler, +16 more
108citations -
Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis
Julia Marie Unglaub, Richard F. Schlenk, Maher Hanoun, Hans Christian Reinhardt, Jan Moritz Middeke, Kerstin Schäfer‐Eckart, +30 more
0citations